{"id":60876,"date":"2024-02-28T07:13:00","date_gmt":"2024-02-28T07:13:00","guid":{"rendered":"https:\/\/medsname.com\/roliten\/"},"modified":"2026-04-30T10:23:41","modified_gmt":"2026-04-30T10:23:41","slug":"roliten","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/roliten\/","title":{"rendered":"Roliten"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:18px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin-top:0;color:#8a5a00;\">R\u0103spuns rapid \u2014 Ce este Roliten?<\/h3>\n<p style=\"margin:0;font-size:15px;line-height:1.6;\"><strong>Roliten<\/strong> con\u021bine <strong>tartrat de tolterodin\u0103<\/strong> \u2014 un antagonist competitiv al receptorilor muscarinici de acetilcolin\u0103 utilizat \u00een tratamentul <strong>vezic\u0103 hiperactiv\u0103 (OAB)<\/strong> cu urgen\u021b\u0103, frecven\u021b\u0103 \u0219i incontinen\u021b\u0103 de urgen\u021b\u0103. Disponibil sub form\u0103 de comprimate cu eliberare imediat\u0103 de 1 mg. <strong>Doza standard: 2 mg de dou\u0103 ori pe zi<\/strong> (sau 1 mg de dou\u0103 ori pe zi \u00een insuficien\u021b\u0103 renal\u0103\/hepatic\u0103 sau cu inhibitori puternici CYP3A4). Pentru dozarea convenabil\u0103 o dat\u0103 pe zi cu un profil de efecte adverse mai uniform, consulta\u021bi <a href=\"https:\/\/medsbase.com\/ro\/terol-la\/\">formula de eliberare prelungit\u0103 (Terol LA). Tolterodina este \u00een general<\/a>. mai bine tolerat\u0103 dec\u00e2t oxibutinina \u2014 mai pu\u021bin\u0103 usc\u0103ciune a gurii, mai pu\u021bin\u0103 constipa\u021bie \u0219i penetrare mai mic\u0103 \u00een SNC. <strong>Utiliza\u021bi cu precau\u021bie la adul\u021bii cu v\u00e2rsta de 65+ ani \u2014 Criteriile Beers 2023 ale Societ\u0103\u021bii Americane de Geriatrie clasific\u0103 toate medicamentele anticholinergice pentru OAB ca \u201epoten\u021bial inadecvate\u201d la v\u00e2rstnici din cauza \u00eenc\u0103rc\u0103turii anticholinergice cumulative.<\/strong> este medicamentul de prim\u0103 inten\u021bie preferat pentru OAB \u00een aceast\u0103 popula\u021bie. <strong>Ce este Roliten?<\/strong> Cum ac\u021bioneaz\u0103 tolterodina. <strong>Mirabegron (Mirago)<\/strong> C\u00e2nd se utilizeaz\u0103 tolterodina.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<div style=\"background:#f4f8fb;border:1px solid #d6e4ec;padding:12px 18px;margin:14px 0;border-radius:4px;font-size:14px;color:#3a5160;text-align:center;\">\n<strong>\ud83d\udd12 Checkout criptat<\/strong> \u00b7 <strong>\ud83d\udcb3 Procesor verificat<\/strong> \u00b7 <strong>\ud83d\ude9a Livrare worldwide<\/strong> \u00b7 <strong>\u2b50 4,9\/5 de la peste 1.400 de clien\u021bi<\/strong>\n<\/div>\n<p><!-- medsbase-why-order --><\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Fiecare lot este procurat de la un <strong>produc\u0103tor certificat WHO-GMP<\/strong>. Comenzile sunt expediate \u00een ambalaje simple, f\u0103r\u0103 marc\u0103, de la partenerii no\u0219tri de onorare \u0219i acoperite de <a href=\"\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a>: dac\u0103 un colet nu ajunge \u00een 20 de zile lucr\u0103toare, trimitem gratuit o nou\u0103 comand\u0103, f\u0103r\u0103 \u00eentreb\u0103ri.<\/p>\n<div style=\"background:#fafafa;border:1px solid #e0e0e0;padding:16px 20px;margin:18px 0;border-radius:4px;\">\n<strong style=\"display:block;margin-bottom:8px;color:#333;\">Pe aceast\u0103 pagin\u0103<\/strong><\/p>\n<ul style=\"margin:0;padding-left:20px;line-height:1.8;\">\n<li><a href=\"#what-is\">\u00cenc\u0103rc\u0103tura anticholinergic\u0103 &amp; v\u00e2rstnicii<\/a><\/li>\n<li><a href=\"#how-it-works\">Compara\u021bie \u00eentre tolterodin\u0103 \u0219i alte medicamente<\/a><\/li>\n<li><a href=\"#uses\">Roliten este un brand de<\/a><\/li>\n<li><a href=\"#how-to-take\">Dozaj \u0219i mod de administrare<\/a><\/li>\n<li><a href=\"#side-effects\">Efecte secundare \u0219i siguran\u021b\u0103<\/a><\/li>\n<li><a href=\"#geriatric\">comprimate cu eliberare imediat\u0103 de tolterodin\u0103 tartrat 1 mg<\/a><\/li>\n<li><a href=\"#contraindications\">Contraindica\u021bii \u0219i avertiz\u0103ri<\/a><\/li>\n<li><a href=\"#interactions\">Interac\u021biuni medicamentoase<\/a><\/li>\n<li><a href=\"#alternatives\">How tolterodine compares<\/a><\/li>\n<li><a href=\"#storage\">Depozitare \u0219i termen de valabilitate<\/a><\/li>\n<li><a href=\"#faq\">\u00centreb\u0103ri frecvente<\/a><\/li>\n<\/ul>\n<\/div>\n<h2 id=\"what-is\" class=\"wp-block-heading\">\u00cenc\u0103rc\u0103tura anticholinergic\u0103 &amp; v\u00e2rstnicii<\/h2>\n<p>Roliten is a brand of <strong>tolterodine tartrate 1 mg immediate-release tablets<\/strong>. Tolterodine este unul dintre cele mai prescrise medicamente antimuscarinice pentru OAB la nivel mondial. Comercializat interna\u021bional sub denumirea <strong>Detrol \/ Detrol LA (SUA), Detrusitol \/ Detrusitol XL (UK \/ UE)<\/strong>. Dimensiuni ale ambalajelor disponibile la MedsBase: 30, 60, 90 sau 180 de comprimate\/capsule.<\/p>\n<h2 id=\"how-it-works\" class=\"wp-block-heading\">Compara\u021bie \u00eentre tolterodin\u0103 \u0219i alte medicamente<\/h2>\n<p>Tolterodina este un antagonist competitiv la <strong>receptorii muscarinici M2 \u0219i M3 pentru acetilcolin\u0103<\/strong>. Blocarea receptorilor M3 din vezic\u0103 reduce contrac\u021biile detrusorului determinate de parasimpatic \u00een timpul fazei de umplere \u2014 diminu\u00e2nd episoadele de urgen\u021b\u0103 \u0219i incontinen\u021b\u0103 \u0219i cresc\u00e2nd capacitatea func\u021bional\u0103 a vezicii.<\/p>\n<p>Comparativ cu <a href=\"https:\/\/medsbase.com\/ro\/oxyspas\/\">oxybutynin<\/a>, tolterodina are o selectivitate u\u0219or mai bun\u0103 pentru receptorii muscarinici din vezic\u0103 fa\u021b\u0103 de cei din glandele salivare, o penetrare mai mic\u0103 \u00een SNC \u0219i un profil de efecte adverse mai favorabil \u2014 \u00een special gur\u0103 uscat\u0103 mai pu\u021bin sever\u0103. Ambele r\u0103m\u00e2n totu\u0219i anticholinergice cu avertismentele standard privind utilizarea la v\u00e2rstnici.<\/p>\n<p>Tolterodina este metabolizat\u0103 de CYP2D6 \u00eentr-un metabolit activ (5-hidroximetil tolterodin\u0103) care contribuie substan\u021bial la efectul clinic. Aproximativ 5-10% din popula\u021bie sunt \u201cmetabolizatori slabi\u201d de CYP2D6 care formeaz\u0103 mai pu\u021bin din metabolit \u0219i necesit\u0103 ajustarea dozei.<\/p>\n<h2 id=\"uses\" class=\"wp-block-heading\">Roliten este un brand de<\/h2>\n<ul>\n<li><strong>Sindromul vezicii hiperactive (OAB)<\/strong> cu urgen\u021b\u0103, frecven\u021b\u0103, incontinen\u021b\u0103 de urgen\u021b\u0103, nicturie \u2014 indica\u021bia autorizat\u0103<\/li>\n<li><strong>Hiperactivitate detrusor neurogen\u0103<\/strong> \u2014 cazuri selectate la adul\u021bi (scleroz\u0103 multipl\u0103, leziuni ale m\u0103duvei spin\u0103rii)<\/li>\n<li><strong>Pacien\u021bi intoleran\u021bi la oxybutynin<\/strong> \u2014 tolterodina este o alegere frecvent\u0103 ca antimuscarinic de rezerv\u0103, cu o tolerabilitate u\u0219or mai bun\u0103<\/li>\n<li><strong>Terapie combinat\u0103 pentru OAB cu mirabegron<\/strong> \u2014 pentru simptome refractare de OAB la pacien\u021bii care tolereaz\u0103 dar nu r\u0103spund complet la monoterapie<\/li>\n<\/ul>\n<h2 id=\"how-to-take\" class=\"wp-block-heading\">Dozaj \u0219i mod de administrare<\/h2>\n<ul>\n<li><strong>Doza standard pentru adul\u021bi: 2 mg de dou\u0103 ori pe zi<\/strong><\/li>\n<li><strong>Doz\u0103 redus\u0103: 1 mg de dou\u0103 ori pe zi<\/strong> pentru: insuficien\u021b\u0103 renal\u0103 semnificativ\u0103 (eGFR &lt;30), insuficien\u021b\u0103 hepatic\u0103 moderat\u0103, inhibitori puternici concomitenti ai CYP3A4 sau pacien\u021bi care tolereaz\u0103 slab doza de 2 mg de dou\u0103 ori pe zi<\/li>\n<li>Administra\u021bi cu sau f\u0103r\u0103 alimente, cu ap\u0103. \u00cenghi\u021bi\u021bi comprimatele \u00eentregi.<\/li>\n<li>Pentru o dozare mai convenabil\u0103 o dat\u0103 pe zi, consulta\u021bi medicul despre <a href=\"https:\/\/medsbase.com\/ro\/terol-la\/\"><strong>Terol LA<\/strong><\/a> (tolterodin\u0103 cu eliberare prelungit\u0103 2 mg \/ 4 mg capsule)<\/li>\n<li>Efectul se dezvolt\u0103 \u00een 4-8 s\u0103pt\u0103m\u00e2ni. Dac\u0103 nu se observ\u0103 beneficiu p\u00e2n\u0103 la 8 s\u0103pt\u0103m\u00e2ni, trece\u021bi la un alt tratament.<\/li>\n<\/ul>\n<h2 id=\"side-effects\" class=\"wp-block-heading\">Efecte secundare \u0219i siguran\u021b\u0103<\/h2>\n<ul>\n<li><strong>Frecvente (1 din 10):<\/strong> <strong>gur\u0103 uscat\u0103<\/strong> (mai pu\u021bin sever dec\u00e2t oxybutynin, dar \u00eenc\u0103 principalul motiv pentru \u00eentreruperea tratamentului), constipa\u021bie, ochi usca\u021bi, vedere \u00eence\u021bo\u0219at\u0103, cefalee, dispepsie, oboseal\u0103<\/li>\n<li><strong>Mai pu\u021bin frecvente:<\/strong> somnolen\u021b\u0103, ame\u021beli, edem periferic, reten\u021bie urinar\u0103 sau ezitare, piele uscat\u0103, cre\u0219tere \u00een greutate<\/li>\n<li><strong>Mai pu\u021bin frecvente, dar importante:<\/strong> confuzie, halucina\u021bii (\u00een special la v\u00e2rstnici), prelungire a intervalului QT (precau\u021bie \u00een cazul medicamentelor concomitente care prelungesc QT)<\/li>\n<li><strong>Rare dar grave:<\/strong> glaucom cu unghi \u00eenchis acut, constipa\u021bie sever\u0103\/ileus paralitic, reten\u021bie urinar\u0103, anafilaxie, angioedem<\/li>\n<\/ul>\n<h2 id=\"geriatric\" class=\"wp-block-heading\">comprimate cu eliberare imediat\u0103 de tolterodin\u0103 tartrat 1 mg<\/h2>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:14px 0;border-radius:4px;\">\n<strong>\u26a0\ufe0f \u00cenc\u0103rc\u0103tur\u0103 anticolinergic\u0103 la v\u00e2rstnici.<\/strong> Medicamentele anticolinergice cresc riscul de c\u0103deri, declin cognitiv, delir \u0219i demen\u021b\u0103 la adul\u021bii \u00een v\u00e2rst\u0103 \u2014 \u00een special atunci c\u00e2nd sunt asociate cu alte substan\u021be anticolinergice (difenhidramin\u0103, hidroxizin\u0103, amitriptilin\u0103, hiosciamin\u0103, scopolamin\u0103, oxybutynin\u0103, tolterodin\u0103). Pentru pacien\u021bii cu v\u00e2rsta de 65 de ani \u0219i peste, mirabegron (un agonist \u03b23) este medicamentul de prima linie preferat pentru sindromul vezicii hiperactive. Criteriile Beers 2023 ale Societ\u0103\u021bii Americane de Geriatrie clasific\u0103 toate medicamentele anticolinergice pentru sindromul vezicii hiperactive ca <strong>\u201cpoten\u021bial inadecvate\u201d<\/strong> la adul\u021bii \u00een v\u00e2rst\u0103.\n<\/div>\n<p>Tolterodina are o penetrare pu\u021bin mai mic\u0103 \u00een sistemul nervos central dec\u00e2t oxybutynina \u0219i este \u00een general considerat\u0103 mai bine tolerat\u0103 dintre cele dou\u0103 medicamente anticolinergice pentru sindromul vezicii hiperactive la adul\u021bii \u00een v\u00e2rst\u0103 \u2014 dar este totu\u0219i clasificat\u0103 ca \u201cpoten\u021bial inadecvat\u0103\u201d \u00een Criteriile Beers \u0219i ar trebui utilizat\u0103 cu precau\u021bie \u0219i la cea mai mic\u0103 doz\u0103 eficace. <strong>Mirabegron r\u0103m\u00e2ne medicamentul de prima linie preferat pentru sindromul vezicii hiperactive la adul\u021bii cu v\u00e2rsta de 65 de ani \u0219i peste<\/strong> atunci c\u00e2nd este accesibil \u0219i nu este contraindicat din cauza hipertensiunii.<\/p>\n<h2 id=\"contraindications\" class=\"wp-block-heading\">Contraindica\u021bii \u0219i avertiz\u0103ri<\/h2>\n<p><strong>Nu lua\u021bi tolterodin\u0103 dac\u0103 ave\u021bi:<\/strong><\/p>\n<ul>\n<li>Glaucom cu unghi \u00eenchis netratat<\/li>\n<li>Reten\u021bie urinar\u0103 sau obstruc\u021bie semnificativ\u0103 a orificiului vezical<\/li>\n<li>Tulbur\u0103ri severe ale motilit\u0103\u021bii gastrointestinale (ileus paralitic, colit\u0103 ulceroas\u0103 sever\u0103, megacolon toxic)<\/li>\n<li>Miastenie gravis<\/li>\n<li>Insuficien\u021b\u0103 hepatic\u0103 sever\u0103<\/li>\n<li>Hipersensibilitate la tolterodin\u0103 sau fesoterodin\u0103 (prodrogul s\u0103u)<\/li>\n<\/ul>\n<p><strong>Folosi\u021bi cu precau\u021bie dac\u0103 ave\u021bi:<\/strong> v\u00e2rst\u0103 \u00eenaintat\u0103 (vezi mai sus), hiperplazie benign\u0103 de prostat\u0103 (risc de reten\u021bie urinar\u0103), esofagit\u0103 de reflux, neuropatie autonom\u0103, prelungire congenital\u0103 sau dob\u00e2ndit\u0103 a intervalului QT, boal\u0103 arterial\u0103 coronarian\u0103.<\/p>\n<h2 id=\"interactions\" class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Inhibitori puternici ai CYP3A4<\/strong> (ketoconazol, itraconazol, ritonavir, claritromicin\u0103, indinavir) \u2014 cresc semnificativ nivelurile de tolterodin\u0103; reduce\u021bi doza la 1 mg de dou\u0103 ori pe zi (IR) sau 2 mg o dat\u0103 pe zi (LA)<\/li>\n<li><strong>Alte anticolinergice<\/strong> \u2014 efecte aditive; minimiza\u021bi suprapunerea (difenhidramin\u0103, hidroxizin\u0103, amitriptilin\u0103, paroxetin\u0103, quetiapin\u0103, hiosciamin\u0103, oxibutinin\u0103)<\/li>\n<li><strong>Inhibitori de colinesteraz\u0103<\/strong> (donepezil, rivastigmin\u0103, galantamin\u0103 pentru demen\u021b\u0103) \u2014 mecanisme opuse; prescrierea concomitent\u0103 a ambelor este ira\u021bional\u0103<\/li>\n<li><strong>Medicamente care prelungesc intervalul QT<\/strong> (antiaritmice de clas\u0103 Ia\/III, unele antipsihotice, antibiotice din clasa chinolonelor) \u2014 risc teoretic aditiv<\/li>\n<li><strong>Medicamente substrat pentru CYP2D6<\/strong> \u2014 tolterodina este metabolizat\u0103 de CYP2D6, astfel c\u0103 metabolizatorii slabi (5-10% din popula\u021bie) au expunere mai mare<\/li>\n<\/ul>\n<h2 id=\"alternatives\" class=\"wp-block-heading\">How tolterodine compares<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Medicament<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Tr\u0103s\u0103tur\u0103 notabil\u0103<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/oxyspas\/\">Oxibutinin\u0103<\/a><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Mai veche, mai ieftin\u0103; cel mai mare risc de gur\u0103 uscat\u0103 \u0219i efecte cognitive<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Tolterodin\u0103 IR \/ LA<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Mai bine tolerat\u0103 dec\u00e2t oxibutinina; LA permite administrare o dat\u0103 pe zi<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Solifenacin\u0103 \/ darifenacin\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Mai selectiv\u0103 pentru receptorii M3; usc\u0103ciunea gurii u\u0219or mai mic\u0103<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/mirago\/\"><strong>Mirabegron<\/strong><\/a><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">agonist \u03b23 \u2014 <strong>preferat ca tratament de prim\u0103 linie la pacien\u021bii peste 65 de ani;<\/strong> f\u0103r\u0103 \u00eenc\u0103rc\u0103tur\u0103 anticolinergic\u0103<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/urispas\/\">Flavoxat (Urispas)<\/a><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Antispastic; util pentru spasmul urinar post-procedural<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 id=\"storage\" class=\"wp-block-heading\">Depozitare \u0219i termen de valabilitate<\/h2>\n<p>P\u0103stra\u021bi Roliten la temperaturi sub 25\u00b0C \u00een ambalajul original blister. Proteja\u021bi de umiditate \u0219i lumin\u0103. Depozita\u021bi \u00eentr-un loc inaccesibil copiilor. Nu utiliza\u021bi dup\u0103 data de expirare.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Care este diferen\u021ba dintre Roliten (IR) \u0219i Terol LA (eliberare prelungit\u0103)?<\/h3>\n<p>Acela\u0219i principiu activ (tartrat de tolterodin\u0103), dar profil de eliberare diferit. <strong>Roliten 1 mg de dou\u0103 ori pe zi<\/strong> utilizeaz\u0103 comprimate cu eliberare imediat\u0103 \u2014 mai ieftine, cu posibilitate de ajustare mai flexibil\u0103 a dozei, dar v\u00e2rfurile \u0219i sc\u0103derile de concentra\u021bie plasmatic\u0103 provoac\u0103 efecte adverse mai variate. <strong>Terol LA 4 mg o dat\u0103 pe zi<\/strong> utilizeaz\u0103 o capsul\u0103 cu eliberare prelungit\u0103 \u2014 profilul plasmatic mai plat se traduce \u00eentr-o usc\u0103ciune a gurii moderat mai mic\u0103, un regim mai simplu (aderen\u021b\u0103 mai bun\u0103). Alege\u021bi forma cu eliberare imediat\u0103 dac\u0103 ave\u021bi nevoie de o titrare mai fin\u0103 a dozei sau dac\u0103 titra\u021bi cu precau\u021bie; trece\u021bi la forma cu ac\u021biune prelungit\u0103 dup\u0103 ce g\u0103si\u021bi o doz\u0103 stabil\u0103.<\/p>\n<h3 class=\"wp-block-heading\">De ce provoac\u0103 tolterodina usc\u0103ciunea gurii?<\/h3>\n<p>Tolterodina blocheaz\u0103 receptorii muscarinici M3 care stimuleaz\u0103 produc\u021bia de saliv\u0103 \u2014 acela\u0219i receptor pe care \u00eel blocheaz\u0103 \u00een vezic\u0103. M\u0103suri de atenuare a efectelor secundare: gum\u0103 de mestecat f\u0103r\u0103 zah\u0103r, \u00eenghi\u021bituri frecvente de ap\u0103, substitut de saliv\u0103 (Biotene). Dac\u0103 usc\u0103ciunea gurii este intolerabil\u0103, <a href=\"https:\/\/medsbase.com\/ro\/mirago\/\">mirabegron (Mirago)<\/a> evit\u0103 complet mecanismul antimuscarinic.<\/p>\n<h3 class=\"wp-block-heading\">C\u00e2t dureaz\u0103 p\u00e2n\u0103 \u00eencepe s\u0103 actioneze tolterodina?<\/h3>\n<p>O ameliorare ini\u021bial\u0103 a urgen\u021bei \u0219i frecven\u021bei se observ\u0103 de obicei \u00een 1-2 s\u0103pt\u0103m\u00e2ni; efectul complet se ob\u021bine \u00een 4-8 s\u0103pt\u0103m\u00e2ni. Dac\u0103 nu se observ\u0103 beneficiu p\u00e2n\u0103 la 8 s\u0103pt\u0103m\u00e2ni la doza maxim\u0103 tolerat\u0103, este rezonabil s\u0103 se treac\u0103 la un alt medicament pentru vezic\u0103 hiperactiv\u0103 (mirabegron, solifenacin\u0103).<\/p>\n<h3 class=\"wp-block-heading\">Pot lua tolterodin\u0103 dac\u0103 am peste 65 de ani?<\/h3>\n<p>Criteriile Beers 2023 ale American Geriatrics Society clasific\u0103 toate medicamentele anticholinergice pentru vezic\u0103 hiperactiv\u0103 ca \u201cpoten\u021bial inadecvate\u201d la adul\u021bii \u00een v\u00e2rst\u0103. Tolterodina este ceva mai bine tolerat\u0103 dec\u00e2t oxibutinina, dar tot poart\u0103 riscul \u00eenc\u0103rc\u0103turii anticholinergice \u2014 c\u0103deri, \u00eencetinire cognitiv\u0103, posibil\u0103 asociere cu demen\u021ba pe termen lung. Discuta\u021bi <strong>mirabegron<\/strong> mai \u00eent\u00e2i cu medicul dumneavoastr\u0103; are eficacitate echivalent\u0103 f\u0103r\u0103 aceste riscuri.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua tolterodin\u0103 cu mirabegron?<\/h3>\n<p>Da \u2014 terapia combinat\u0103 cu o doz\u0103 mic\u0103 de anticholinergic plus mirabegron este bine documentat\u0103 pentru simptomele refractare ale vezicii hiperactive (date de tip BESIDE). Monitoriza\u021bi reten\u021bia urinar\u0103, \u00een special la b\u0103rba\u021bii cu obstruc\u021bie a ie\u0219irii vezicii.<\/p>\n<h3 class=\"wp-block-heading\">Va afecta tolterodina conducerea sau munca?<\/h3>\n<p>Somnolenta, ame\u021belile \u0219i vederea \u00eence\u021bo\u0219at\u0103 pot afecta conducerea sau operarea ma\u0219inilor. Evita\u021bi p\u00e2n\u0103 c\u00e2nd \u0219ti\u021bi cum v\u0103 afecteaz\u0103 medicamentul. Efectele se atenueaz\u0103 de obicei dup\u0103 primele 1-2 s\u0103pt\u0103m\u00e2ni.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot comanda Roliten online?<\/h3>\n<p>Pute\u021bi comanda Roliten de la MedsBase \u00een dimensiuni standard de ambalaj. Comenzile se expediaz\u0103 \u00een \u00eentreaga lume cu ambalaj discret. Tolterodina este supus\u0103 supravegherii specializate la nivel mondial.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\">\n<strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui profesionist calificat \u00een domeniul s\u0103n\u0103t\u0103\u021bii. Consulta\u021bi \u00eentotdeauna medicul sau farmacistul \u00eenainte de a \u00eencepe, modifica sau \u00eentrerupe orice tratament pentru simptome urinare sau de prostat\u0103 \u2014 acestea pot fi semnele timpurii ale unor afec\u021biuni (infec\u021bie urinar\u0103, cancer de prostat\u0103, pietre vezicale) care necesit\u0103 diagnostic \u0219i tratament \u021bintit, nu doar ameliorare simptomatic\u0103. MedsBase nu ofer\u0103 diagnostic, prescrip\u021bie sau recomand\u0103ri clinice.\n<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>S\u0103n\u0103tate general\u0103<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tinima\/\">Tinima<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/esoprol\/\">Esoprol<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/busiron\/\">Busiron<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/qutan-sr-400\/\">Qutan SR 400<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/pentids-2\/\">Pentids<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Reduce frecven\u021ba urinar\u0103<br \/>\n\u2705 Controlul incontinen\u021bei de urgen\u021b\u0103<br \/>\n\u2705 Amelioreaz\u0103 spasmele vezicale<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te fluxul urinar<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te controlul vezical<\/p>\n<p>Roliten con\u021bine Tolterodin\u0103.<\/p>","protected":false},"featured_media":60877,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3614,3141,3342],"product_tag":[4939,4940],"class_list":{"0":"post-60876","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-bladder-prostate","7":"product_cat-category-overview","8":"product_cat-general-health","9":"product_tag-roliten","10":"product_tag-tolterodine","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/60876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=60876"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/60877"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=60876"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=60876"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=60876"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=60876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}